Skip to main content
David Adams, MD, Neurology, Miami, FL, University of Miami Hospital

DavidJ.AdamsMD

Neurology Miami, FL

Clinical Professor of Neurology, University Miami School of Medicine

Dr. Adams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Adams' full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1970 - 1974
  • University of Washington School of Medicine
    University of Washington School of MedicineInternship, Transitional Year, 1969 - 1970
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1969

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2008 - 2024
  • NY State Medical License
    NY State Medical License 1970 - 2009
  • NJ State Medical License
    NJ State Medical License 1978 - 2007
  • GA State Medical License
    GA State Medical License 1992 - 1995
  • NC State Medical License
    NC State Medical License 1972 - 1982
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Press Mentions

  • Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy: French Experience About Four Patients, Under the Behalf of French Society for Bone Marrow Transplantation
    Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy: French Experience About Four Patients, Under the Behalf of French Society for Bone Marrow TransplantationMarch 2nd, 2021
  • Oligonucleotide Drugs Show Promise in Transthyretin Amyloidosis
    Oligonucleotide Drugs Show Promise in Transthyretin AmyloidosisJuly 5th, 2018
  • Alnylam RNAi Drug Reverses Progress of Rare Fatal Disease: Study
    Alnylam RNAi Drug Reverses Progress of Rare Fatal Disease: StudyNovember 2nd, 2017
  • Join now to see all

Hospital Affiliations